Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

• Publication date: November 2009

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015 Summary GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the global IVD market. The report provides market landscape, competitive landscape and market trends information on seven market categories including clinical chemistry, genetic testing, histology and cytolog...

Global In Vitro Diagnostics Market Analysis and Forecasts to 2015

Summary

GlobalData’s “Global In Vitro Diagnostics (IVD) Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the global IVD market. The report provides market landscape, competitive landscape and market trends information on seven market categories including clinical chemistry, genetic testing, histology and cytology, immunochemistry, infectious immunology, microbiology culture and haematology. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.

Scope

- Forecasts & Analysis of the global IVD market to 2015.
- Geographical coverage across 12 major countries which include the US (United States), the UK (United Kingdom), France, Italy, Spain, Canada, Germany, Japan, India, China, Australia and Brazil
- Market segmentation by clinical chemistry, genetic testing, histology and cytology, immunochemistry, infectious immunology, microbiology culture and haematology.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis. Key companies covered include F. Hoffmann-La Roche Ltd, Siemens Medical Solutions, Abbott Laboratories, Beckman Coulter, Inc., Biomerieux Sa and Ortho-Clinical Diagnostics Inc.
- Analysis of key IVD pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.

Reasons to buy

- Understand what the new growth opportunities are within the global IVD market.
- Develop a clear knowledge & understanding of the global IVD competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the global IVD market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.

In Vitro Diagnostic Industry in South America

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Executive Summary
4 Definitions of Markets Covered in This Report
4.1 In Vitro Diagnostics
4.2 Blood Test Reagents
4.3 Clinical Chemistry Test Reagents
4.4 Genetic Test Reagents
4.5 Immunochemistry Test Reagents
4.6 Infectious Immunology Test Reagents
4.7 Instruments
4.8 Microbiology Test Reagents
4.9 Self Testing
5 Global In Vitro Diagnostics
5.1 In Vitro Diagnostics, Global, Overall Revenue ($m), 2000-2015
5.2 In Vitro Diagnostics Market Dynamic
5.3 In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015
5.4 In Vitro Diagnostics, Global, Competitive Landscape
6 In Vitro Diagnostics Cross Country Comparison
6.1 In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015
7 In Vitro Diagnostics In US
7.1 In Vitro Diagnostics, US, Overall Revenue ($m), 2000-2015
7.2 In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015
7.3 In Vitro Diagnostics, US, Distribution Share (2007-2008)
7.4 In Vitro Diagnostics, US, Company Share (2007-2008)
8 In Vitro Diagnostics In Japan
8.1 In Vitro Diagnostics, Japan, Overall Revenue ($m), 2000-2015
8.2 In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015
8.3 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)
8.4 In Vitro Diagnostics, Japan, Company Share (2007-2008)
9 In Vitro Diagnostics In Germany
9.1 In Vitro Diagnostics, Germany, Overall Revenue ($m), 2000-2015
9.2 In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015
9.3 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)
9.4 In Vitro Diagnostics, Germany, Company Share (2007-2008)
10 In Vitro Diagnostics In Italy
10.1 In Vitro Diagnostics, Italy, Overall Revenue ($m), 2000-2015
10.2 In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015
10.3 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)
10.4 In Vitro Diagnostics, Italy, Company Share (2007-2008)
11 In Vitro Diagnostics In France
11.1 In Vitro Diagnostics, France, Overall Revenue ($m), 2000-2015
11.2 In Vitro Diagnostics, France, Cross-Category Analysis, 2000-2015
11.3 In Vitro Diagnostics, France, Distribution Share (2007-2008)
11.4 In Vitro Diagnostics, France, Company Share (2007-2008)
12 In Vitro Diagnostics In China
12.1 In Vitro Diagnostics, China, Overall Revenue ($m), 2000-2015
12.2 In Vitro Diagnostics, China, Cross-Category Analysis, 2000-2015
12.3 In Vitro Diagnostics, China, Distribution Share (2007-2008)
12.4 In Vitro Diagnostics, China, Company Share (2007-2008)
13 In Vitro Diagnostics In Spain
13.1 In Vitro Diagnostics, Spain, Overall Revenue ($m), 2000-2015
13.2 In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015
13.3 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)
13.4 In Vitro Diagnostics, Spain, Company Share (2007-2008)
14 In Vitro Diagnostics In UK
14.1 In Vitro Diagnostics, UK, Overall Revenue ($m), 2000-2015
14.2 In Vitro Diagnostics, UK, Cross-Category Analysis, 2000-2015
14.3 In Vitro Diagnostics, UK, Distribution Share (2007-2008)
14.4 In Vitro Diagnostics, UK, Company Share (2007-2008)
15 In Vitro Diagnostics In Brazil
15.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), 2000-2015
15.2 In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015
15.3 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)
15.4 In Vitro Diagnostics, Brazil, Company Share (2007-2008)
16 In Vitro Diagnostics In Canada
16.1 In Vitro Diagnostics, Canada, Overall Revenue ($m), 2000-2015
16.2 In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-2015
16.3 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)
16.4 In Vitro Diagnostics, Canada, Company Share (2007-2008)
17 In Vitro Diagnostics In India
17.1 In Vitro Diagnostics, India, Overall Revenue ($m), 2000-2015
17.2 In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015
17.3 In Vitro Diagnostics, India, Distribution Share (2007-2008)
17.4 In Vitro Diagnostics, India, Company Share (2007-2008)
18 In Vitro Diagnostics In Australia
18.1 In Vitro Diagnostics, Australia, Overall Revenue ($m), 2000-2015
18.2 In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015
18.3 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)
18.4 In Vitro Diagnostics, Australia, Company Share (2007-2008)
19 Overview of Key Companies in In Vitro Diagnostics Market
19.1 F. Hoffmann-La Roche Ltd.
19.2 Siemens Healthcare
19.3 Abbott Laboratories
19.4 Beckman Coulter, Inc.
19.5 Ortho-Clinical Diagnostics Inc.
19.6 bioMerieux S.A.
20 Financial Deals Landscape
20.1 Financial Deal Analysis Deal Type
20.2 Financial Deal Analysis – Deal Value and Volume
20.3 Merger
20.4 Acquisition
20.5 Partnerships
21 Recent Developments
21.1 Strategy And Business Planning
21.2 Legal and Regulatory
21.3 Government and Public Interest
21.4 Other Significant Developments
22 Appendix
22.1 GlobalData Research Methodology
22.2 Secondary Research
22.3 Primary Research
22.4 Models
22.5 Forecasts
22.6 Expert Panel Validation
22.7 Currency Conversion
22.8 Contact Us
22.9 Disclaimer
1.1 List of Tables


Table 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008 36
Table 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015 38
Table 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015 42
Table 4: In Vitro Diagnostics, Global, Company share by Revenue ($m), 2007-2008 44
Table 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 – 2015 46
Table 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015 48
Table 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008 50
Table 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015 52
Table 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015 54
Table 10: Clinical Chemistry, US, Distribution Share by Revenue ($m), 2007-2008 55
Table 11: Genetic Testing, US, Distribution Share by Revenue ($m), 2007-2008 55
Table 12: Haematology, US, Distribution Share by Revenue ($m), 2007-2008 56
Table 13: Histology And Cytology, US, Distribution Share by Revenue ($m), 2007-2008 56
Table 14: Immuno Chemistry, US, Distribution Share by Revenue ($m), 2007-2008 57
Table 15: Infectious Immunology, US, Distribution Share by Revenue ($m), 2007-2008 57
Table 16: Microbiology Culture, US, Distribution Share by Revenue ($m), 2007-2008 58
Table 17: In Vitro Diagnostics, US, Company Share by Revenue ($m), 2008-2008 60
Table 18: Clinical Chemistry, US, Company Share by Revenue ($m), 2007-2008 62
Table 19: Genetic Testing, US, Company Share by Revenue ($m), 2007-2008 64
Table 20: Haematology, US, Company Share by Revenue ($m), 2007-2008 65
Table 21: Histology And Cytology, US, Company Share by Revenue ($m), 2007-2008 66
Table 22: Immuno Chemistry, US, Company Share by Revenue ($m), 2007-2008 68
Table 23: Infectious Immunology, US, Company Share by Revenue ($m), 2007-2008 70
Table 24: Microbiology Culture, US, Company Share by Revenue ($m), 2007-2008 71
Table 25: In Vitro Diagnostics, Japan, Overall Revenue ($m), Historic, 2000-2008 73
Table 26: In Vitro Diagnostics, Japan, Overall Revenue ($m), Forecast, 2008-2015 75
Table 27: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015 77
Table 28: Clinical Chemistry, Japan, Distribution Share by Revenue ($m), 2007-2008 78
Table 29: Genetic Testing, Japan, Distribution Share by Revenue ($m), 2007-2008 78
Table 30: Haematology, Japan, Distribution Share by Revenue ($m), 2007-2008 79
Table 31: Histology And Cytology, Japan, Distribution Share by Revenue ($m), 2007-2008 79
Table 32: Immuno Chemistry, Japan, Distribution Share by Revenue ($m), 2007-2008 80
Table 33: Infectious Immunology, Japan, Distribution Share by Revenue ($m), 2007-2008 80
Table 34: Microbiology Culture, Japan, Distribution Share by Revenue ($m), 2007-2008 81
Table 35: In Vitro Diagnostics, Japan, Company Share by Revenue ($m), 2008-2008 83
Table 36: Clinical Chemistry, Japan, Company Share by Revenue ($m), 2007-2008 85
Table 37: Genetic Testing, Japan, Company Share by Revenue ($m), 2007-2008 87
Table 38: Haematology, Japan, Company Share by Revenue ($m), 2007-2008 89
Table 39: Histology And Cytology, Japan, Company Share by Revenue ($m), 2007-2008 91
Table 40: Immuno Chemistry, Japan, Company Share by Revenue ($m), 2007-2008 93
Table 41: Infectious Immunology, Japan, Company Share by Revenue ($m), 2007-2008 95
Table 42: Microbiology Culture, Japan, Company Share by Revenue ($m), 2007-2008 97
Table 43: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2000-2008 99
Table 44: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2008-2015 101
Table 45: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015 103
Table 46: Clinical Chemistry, Germany, Distribution Share by Revenue ($m), 2007-2008 104
Table 47: Genetic Testing, Germany, Distribution Share by Revenue ($m), 2007-2008 104
Table 48: Haematology, Germany, Distribution Share by Revenue ($m), 2007-2008 105
Table 49: Histology And Cytology, Germany, Distribution Share by Revenue ($m), 2007-2008 105
Table 50: Immuno Chemistry, Germany, Distribution Share by Revenue ($m), 2007-2008 106
Table 51: Infectious Immunology, Germany, Distribution Share by Revenue ($m), 2007-2008 106
Table 52: Microbiology Culture, Germany, Distribution Share by Revenue ($m), 2007-2008 107
Table 53: In Vitro Diagnostics, Germany, Company Share by Revenue ($m), 2008-2008 109
Table 54: Clinical Chemistry, Germany, Company Share by Revenue ($m), 2007-2008 111
Table 55: Genetic Testing, Germany, Company Share by Revenue ($m), 2007-2008 112
Table 56: Haematology, Germany, Company Share by Revenue ($m), 2007-2008 114
Table 57: Histology And Cytology, Germany, Company Share by Revenue ($m), 2007-2008 116
Table 58: Immuno Chemistry, Germany, Company Share by Revenue ($m), 2007-2008 118
Table 59: Infectious Immunology, Germany, Company Share by Revenue ($m), 2007-2008 120
Table 60: Microbiology Culture, Germany, Company Share by Revenue ($m), 2007-2008 122
Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($m), Historic, 2000-2008 124
Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($m), Forecast, 2008-2015 126
Table 63: In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015 128
Table 64: Clinical Chemistry, Italy, Distribution Share by Revenue ($m), 2007-2008 129
Table 65: Genetic Testing, Italy, Distribution Share by Revenue ($m), 2007-2008 129
Table 66: Haematology, Italy, Distribution Share by Revenue ($m), 2007-2008 130
Table 67: Histology And Cytology, Italy, Distribution Share by Revenue ($m), 2007-2008 130
Table 68: Immuno Chemistry, Italy, Distribution Share by Revenue ($m), 2007-2008 131
Table 69: Infectious Immunology, Italy, Distribution Share by Revenue ($m), 2007-2008 131
Table 70: Microbiology Culture, Italy, Distribution Share by Revenue ($m), 2007-2008 132
Table 71: In Vitro Diagnostics, Italy, Company Share by Revenue ($m), 2008-2008 134
Table 72: Clinical Chemistry, Italy, Company Share by Revenue ($m), 2007-2008 136
Table 73: Genetic Testing, Italy, Company Share by Revenue ($m), 2007-2008 138
Table 74: Haematology, Italy, Company Share by Revenue ($m), 2007-2008 140
Table 75: Histology And Cytology, Italy, Company Share by Revenue ($m), 2007-2008 142
Table 76: Immuno Chemistry, Italy, Company Share by Revenue ($m), 2007-2008 144
Table 77: Infectious Immunology, Italy, Company Share by Revenue ($m), 2007-2008 146
Table 78: Microbiology Culture, Italy, Company Share by Revenue ($m), 2007-2008 148
Table 79: In Vitro Diagnostics, France, Overall Revenue ($m), Historic, 2000-2008 150
Table 80: In Vitro Diagnostics, France, Overall Revenue ($m), Forecast, 2008-2015 152
Table 81: In Vitro Diagnostics, France, Cross-Category Analysis, 2000-2015 154
Table 82: Clinical Chemistry, France, Distribution Share by Revenue ($m), 2007-2008 155
Table 83: Genetic Testing, France, Distribution Share by Revenue ($m), 2007-2008 155
Table 84: Haematology, France, Distribution Share by Revenue ($m), 2007-2008 156
Table 85: Histology And Cytology, France, Distribution Share by Revenue ($m), 2007-2008 156
Table 86: Immuno Chemistry, France, Distribution Share by Revenue ($m), 2007-2008 157
Table 87: Infectious Immunology, France, Distribution Share by Revenue ($m), 2007-2008 157
Table 88: Microbiology Culture, France, Distribution Share by Revenue ($m), 2007-2008 158
Table 89: In Vitro Diagnostics, France, Company Share by Revenue ($m), 2008-2008 160
Table 90: Clinical Chemistry, France, Company Share by Revenue ($m), 2007-2008 162
Table 91: Genetic Testing, France, Company Share by Revenue ($m), 2007-2008 164
Table 92: Haematology, France, Company Share by Revenue ($m), 2007-2008 166
Table 93: Histology And Cytology, France, Company Share by Revenue ($m), 2007-2008 167
Table 94: Immuno Chemistry, France, Company Share by Revenue ($m), 2007-2008 169
Table 95: Infectious Immunology, France, Company Share by Revenue ($m), 2007-2008 171
Table 96: Microbiology Culture, France, Company Share by Revenue ($m), 2007-2008 173
Table 97: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2000-2008 175
Table 98: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2008-2015 177
Table 99: In Vitro Diagnostics, China, Cross-Category Analysis, 2000-2015 179
Table 100: Clinical Chemistry, China, Distribution Share by Revenue ($m), 2007-2008 180
Table 101: Genetic Testing, China, Distribution Share by Revenue ($m), 2007-2008 180
Table 102: Haematology, China, Distribution Share by Revenue ($m), 2007-2008 181
Table 103: Histology And Cytology, China, Distribution Share by Revenue ($m), 2007-2008 181
Table 104: Immuno Chemistry, China, Distribution Share by Revenue ($m), 2007-2008 182
Table 105: Infectious Immunology, China, Distribution Share by Revenue ($m), 2007-2008 182
Table 106: Microbiology Culture, China, Distribution Share by Revenue ($m), 2007-2008 183
Table 107: In Vitro Diagnostics, China, Company Share by Revenue ($m), 2008-2008 185
Table 108: Clinical Chemistry, China, Company Share by Revenue ($m), 2007-2008 187
Table 109: Genetic Testing, China, Company Share by Revenue ($m), 2007-2008 189
Table 110: Haematology, China, Company Share by Revenue ($m), 2007-2008 191
Table 111: Histology And Cytology, China, Company Share by Revenue ($m), 2007-2008 193
Table 112: Immuno Chemistry, China, Company Share by Revenue ($m), 2007-2008 195
Table 113: Infectious Immunology, China, Company Share by Revenue ($m), 2007-2008 197
Table 114: Microbiology Culture, China, Company Share by Revenue ($m), 2007-2008 199
Table 115: In Vitro Diagnostics, Spain, Overall Revenue ($m), Historic, 2000-2008 201
Table 116: In Vitro Diagnostics, Spain, Overall Revenue ($m), Forecast, 2008-2015 203
Table 117: In Vitro Diagnostics, Spain, Cross-Category Analysis, 2000-2015 205
Table 118: Clinical Chemistry, Spain, Distribution Share by Revenue ($m), 2007-2008 206
Table 119: Genetic Testing, Spain, Distribution Share by Revenue ($m), 2007-2008 206
Table 120: Haematology, Spain, Distribution Share by Revenue ($m), 2007-2008 207
Table 121: Histology and Cytology, Spain, Distribution Share by Revenue ($m), 2007-2008 207
Table 122: Immuno Chemistry, Spain, Distribution Share by Revenue ($m), 2007-2008 208
Table 123: Infectious Immunology, Spain, Distribution Share by Revenue ($m), 2007-2008 208
Table 124: Microbiology Culture, Spain, Distribution Share by Revenue ($m), 2007-2008 209
Table 125: In Vitro Diagnostics, Spain, Company Share by Revenue ($m), 2008-2008 211
Table 126: Clinical Chemistry, Spain, Company Share by Revenue ($m), 2007-2008 213
Table 127: Genetic Testing, Spain, Company Share by Revenue ($m), 2007-2008 215
Table 128: Haematology, Spain, Company Share by Revenue ($m), 2007-2008 217
Table 129: Histology And Cytology, Spain, Company Share by Revenue ($m), 2007-2008 219
Table 130: Immuno Chemistry, Spain, Company Share by Revenue ($m), 2007-2008 221
Table 131: Infectious Immunology, Spain, Company Share by Revenue ($m), 2007-2008 223
Table 132: Microbiology Culture, Spain, Company Share by Revenue ($m), 2007-2008 225
Table 133: In Vitro Diagnostics, UK, Overall Revenue ($m), Historic, 2000-2008 227
Table 134: In Vitro Diagnostics, UK, Overall Revenue ($m), Forecast, 2008-2015 229
Table 135: In Vitro Diagnostics, UK, Cross-Category Analysis, 2000-2015 231
Table 136: Clinical Chemistry, UK, Distribution Share by Revenue ($m), 2007-2008 232
Table 137: Genetic Testing, UK, Distribution Share by Revenue ($m), 2007-2008 232
Table 138: Haematology, UK, Distribution Share by Revenue ($m), 2007-2008 233
Table 139: Histology And Cytology, UK, Distribution Share by Revenue ($m), 2007-2008 233
Table 140: Immuno Chemistry, UK, Distribution Share by Revenue ($m), 2007-2008 234
Table 141: Infectious Immunology, UK, Distribution Share by Revenue ($m), 2007-2008 234
Table 142: Microbiology Culture, UK, Distribution Share by Revenue ($m), 2007-2008 235
Table 143: In Vitro Diagnostics, UK, Company Share by Revenue ($m), 2008-2008 237
Table 144: Clinical Chemistry, UK, Company Share by Revenue ($m), 2007-2008 239
Table 145: Genetic Testing, UK, Company Share by Revenue ($m), 2007-2008 240
Table 146: Haematology, UK, Company Share by Revenue ($m), 2007-2008 242
Table 147: Histology and Cytology, UK, Company Share by Revenue ($m), 2007-2008 244
Table 148: Immuno Chemistry, UK, Company Share by Revenue ($m), 2007-2008 246
Table 149: Infectious Immunology, UK, Company Share by Revenue ($m), 2007-2008 248
Table 150: Microbiology Culture, UK, Company Share by Revenue ($m), 2007-2008 250
Table 151: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Historic, 2000-2008 252
Table 152: In Vitro Diagnostics, Brazil, Overall Revenue ($m), Forecast, 2008-2015 254
Table 153: In Vitro Diagnostics, Brazil, Cross-Category Analysis, 2000-2015 256
Table 154: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), 2007-2008 257
Table 155: Genetic Testing, Brazil, Distribution Share by Revenue ($m), 2007-2008 257
Table 156: Haematology, Brazil, Distribution Share by Revenue ($m), 2007-2008 258
Table 157: Histology and Cytology, Brazil, Distribution Share by Revenue ($m), 2007-2008 258
Table 158: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), 2007-2008 259
Table 159: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), 2007-2008 259
Table 160: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), 2007-2008 260
Table 161: In Vitro Diagnostics, Brazil, Company Share by Revenue ($m), 2008-2008 262
Table 162: Clinical Chemistry, Brazil, Company Share by Revenue ($m), 2007-2008 264
Table 163: Genetic Testing, Brazil, Company Share by Revenue ($m), 2007-2008 266
Table 164: Haematology, Brazil, Company Share by Revenue ($m), 2007-2008 268
Table 165: Histology and Cytology, Brazil, Company Share by Revenue ($m), 2007-2008 270
Table 166: Immuno Chemistry, Brazil, Company Share by Revenue ($m), 2007-2008 272
Table 167: Infectious Immunology, Brazil, Company Share by Revenue ($m), 2007-2008 274
Table 168: Microbiology Culture, Brazil, Company Share by Revenue ($m), 2007-2008 276
Table 169: In Vitro Diagnostics, Canada, Overall Revenue ($m), Historic, 2000-2008 278
Table 170: In Vitro Diagnostics, Canada, Overall Revenue ($m), Forecast, 2008-2015 280
Table 171: In Vitro Diagnostics, Canada, Cross-Category Analysis, 2000-2015 282
Table 172: Clinical Chemistry, Canada, Distribution Share by Revenue ($m), 2007-2008 283
Table 173: Genetic Testing, Canada, Distribution Share by Revenue ($m), 2007-2008 283
Table 174: Haematology, Canada, Distribution Share by Revenue ($m), 2007-2008 284
Table 175: Histology And Cytology, Canada, Distribution Share by Revenue ($m), 2007-2008 284
Table 176: Immuno Chemistry, Canada, Distribution Share by Revenue ($m), 2007-2008 285
Table 177: Infectious Immunology, Canada, Distribution Share by Revenue ($m), 2007-2008 285
Table 178: Microbiology Culture, Canada, Distribution Share by Revenue ($m), 2007-2008 286
Table 179: In Vitro Diagnostics, Canada, Company Share by Revenue ($m), 2008-2008 288
Table 180: Clinical Chemistry, Canada, Company Share by Revenue ($m), 2007-2008 290
Table 181: Genetic Testing, Canada, Company Share by Revenue ($m), 2007-2008 292
Table 182: Haematology, Canada, Company Share by Revenue ($m), 2007-2008 294
Table 183: Histology and Cytology, Canada, Company Share by Revenue ($m), 2007-2008 296
Table 184: Immuno Chemistry, Canada, Company Share by Revenue ($m), 2007-2008 298
Table 185: Infectious Immunology, Canada, Company Share by Revenue ($m), 2007-2008 300
Table 186: Microbiology Culture, Canada, Company Share by Revenue ($m), 2007-2008 302
Table 187: In Vitro Diagnostics, India, Overall Revenue ($m), Historic, 2000-2008 304
Table 188: In Vitro Diagnostics, India, Overall Revenue ($m), Forecast, 2008-2015 306
Table 189: In Vitro Diagnostics, India, Cross-Category Analysis, 2000-2015 308
Table 190: Clinical Chemistry, India, Distribution Share by Revenue ($m), 2007-2008 309
Table 191: Genetic Testing, India, Distribution Share by Revenue ($m), 2007-2008 309
Table 192: Haematology, India, Distribution Share by Revenue ($m), 2007-2008 310
Table 193: Histology and Cytology, India, Distribution Share by Revenue ($m), 2007-2008 310
Table 194: Immuno Chemistry, India, Distribution Share by Revenue ($m), 2007-2008 311
Table 195: Infectious Immunology, India, Distribution Share by Revenue ($m), 2007-2008 311
Table 196: Microbiology Culture, India, Distribution Share by Revenue ($m), 2007-2008 312
Table 197: In Vitro Diagnostics, India, Company Share by Revenue ($m), 2008-2008 314
Table 198: Clinical Chemistry, India, Company Share by Revenue ($m), 2007-2008 316
Table 199: Genetic Testing, India, Company Share by Revenue ($m), 2007-2008 318
Table 200: Haematology, India, Company Share by Revenue ($m), 2007-2008 320
Table 201: Histology and Cytology, India, Company Share by Revenue ($m), 2007-2008 322
Table 202: Immuno Chemistry, India, Company Share by Revenue ($m), 2007-2008 324
Table 203: Infectious Immunology, India, Company Share by Revenue ($m), 2007-2008 326
Table 204: Microbiology Culture, India, Company Share by Revenue ($m), 2007-2008 328
Table 205: In Vitro Diagnostics, Australia, Overall Revenue ($m), Historic, 2000-2008 330
Table 206: In Vitro Diagnostics, Australia, Overall Revenue ($m), Forecast, 2008-2015 332
Table 207: In Vitro Diagnostics, Australia, Cross-Category Analysis, 2000-2015 334
Table 208: Clinical Chemistry, Australia, Distribution Share by Revenue ($m), 2007-2008 335
Table 209: Genetic Testing, Australia, Distribution Share by Revenue ($m), 2007-2008 335
Table 210: Haematology, Australia, Distribution Share by Revenue ($m), 2007-2008 336
Table 211: Histology and Cytology, Australia, Distribution Share by Revenue ($m), 2007-2008 336
Table 212: Immuno Chemistry, Australia, Distribution Share by Revenue ($m), 2007-2008 337
Table 213: Infectious Immunology, Australia, Distribution Share by Revenue ($m), 2007-2008 337
Table 214: Microbiology Culture, Australia, Distribution Share by Revenue ($m), 2007-2008 338
Table 215: In Vitro Diagnostics, Australia, Company Share by Revenue ($m), 2008-2008 340
Table 216: Clinical Chemistry, Australia, Company Share by Revenue ($m), 2007-2008 342
Table 217: Genetic Testing, Australia, Company Share by Revenue ($m), 2007-2008 344
Table 218: Haematology, Australia, Company Share by Revenue ($m), 2007-2008 346
Table 219: Histology and Cytology, Australia, Company Share by Revenue ($m), 2007-2008 347
Table 220: Immuno Chemistry, Australia, Company Share by Revenue ($m), 2007-2008 349
Table 221: Infectious Immunology, Australia, Company Share by Revenue ($m), 2007-2008 351
Table 222: Microbiology Culture, Australia, Company Share by Revenue ($m), 2007-2008 353
Table 223: Abbott Laboratories Pipeline Products by Equipment Type 356
Table 224: Abbott Laboratories Pipeline Products By Development Stage 356
Table 225: Abbott Laboratories Pipeline Products By Therapy Area 357
Table 226: Beckman Coulter, Inc. Pipeline Products by Equipment Type 359
Table 227: Beckman Coulter, Inc. Pipeline Products By Development Stage 360
Table 228: Beckman Coulter, Inc. Pipeline Products By Therapy Area 361
Table 229: Beckman Coulter, Inc. Pipeline Products By News Summary 361
Table 230: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 362
Table 231: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 363
Table 232: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 363
Table 233: ViraCor Laboratories To Merge With IBT Laboratories 367
Table 234: Bookham Merges With AVANEX To Form Oclaro 368
Table 235: Sorrento Therapeutics Completes Reverse Acquisition With QuikByte Software 370
Table 236: Corning Acquires Axygen BioScience And Its Subsidiaries From American Capital 371
Table 237: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 373
Table 238: PerkinElmer Acquires Surendra Genetic Labs 374
Table 239: Cell Biosciences Enters Into Agreement To Acquire Alpha Innotech 375
Table 240: Thermo Fisher Scientific To Acquire B.R.A.H.M.S. 377
Table 241: Danaher To Acquire Remaining 50% Interest In AB SCIEX 378
Table 242: Danaher To Acquire Analytical Technologies From MDS 379
Table 243: Dia-B Tech Terminates Acquisition Of Pallane Medical 381
Table 244: Quest Diagnostics Acquires Caritas Medical Laboratories From Caritas Christi Health Care 382
Table 245: Inverness Medical Innovations Completes Acquisition Of Concateno From Marwyn 383
Table 246: Laboratory Corporation of America Holdings Completes Acquisition Of Monogram Biosciences 385
Table 247: Agilent Technologies To Acquire Varian 387
Table 248: Bostwick To Acquire CBI Services And Fairfax Identity Laboratories From Commonwealth 388
Table 249: Enigma Diagnostics To Receive Equity Investment From GlaxoSmithKline 390
Table 250: Caio Auriemo Completes Sale Of Stake In Diagnosticos da America 391
Table 251: Sonic Healthcare To Acquire 100% Of Lademannbogen Laboratory 392
Table 252: Adeona Pharmaceuticals Completes Acquisition Of Hartlab 393
Table 253: ICON Acquires Veeda Laboratories From Veeda Clinical Research 394
Table 254: Barclays Bank And The Royal Bank of Scotland Receives Approval To Acquire USP Group 395
Table 255: TOPTICA Photonics Acquires TILL Photonics From Agilent Technologies 396
Table 256: QIAGEN Enters Into An Agreement With Roche And Idaho Technology 397
Table 257: AbD Serotec Enters Into Research Collaboration With Foundation for Innovative New Diagnostics 398
Table 258: Warnex Signs Distribution Agreement With Biron-Laboratoire medical 399
Table 259: Immunodiagnostic Systems Holdings Enters Into Licensing Agreement With Biosignatures 400
Table 260: Accumetrics Enters Into Agreement With Grifols 401
Table 261: Anteo Diagnostics Enters Into An Agreement With DioSion Diagnostics 402
Table 262: IRIS International Enters Into Exclusive Distribution Agreement With Fujirebio 403
Table 263: Rosetta Genomics Enters Into Distribution Agreement With Super Religare Laboratories 404
Table 264: Epigenomics Signs Licensing Agreement With ARUP Laboratories 405
Table 265: Horizon Discovery Enters Into An Agreement With Newcastle University 406
Table 266: Warnex Signs Distribution Agreement With Rosetta Genomics 407
Table 267: Lab21 Enters Into Distribution Agreement With AdnaGen 408
Table 268: Celera Enters Into Agreement With Aurora Health Care 409
Table 269: The Addario Lung Cancer Medical Institute Enters Into An Agreement With Response Genetics 410
Table 270: QuantRx Biomedical Enters Into Joint Venture Agreement With NuRx Pharmaceuticals 411
Table 271: DxS Signs Cross-Licensing Agreement With Epigenomics 412
Table 272: Enigma Diagnostics Enters Into An Agreement With Roche Molecular Systems 413
Table 273: IVAX Diagnostics Amends Its Distribution Agreement With IMMCO Diagnostics 414
Table 274: IVAX Diagnostics Signs Distribution Agreement With Augurix 415
Table 275: Prodesse Enters Into A licensing Agreement With Abbott Laboratories 416
Table 276: USD to Local Currency, Average Exchange Rate 2008 466
1.2 List of Figures


Figure 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008 35
Figure 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015 37
Figure 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015 41
Figure 4: In Vitro Diagnostics, Global, Company share (%), 2008 43
Figure 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 – 2015 45
Figure 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015 47
Figure 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008 49
Figure 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015 51
Figure 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015 53
Figure 10: In Vitro Diagnostics, US, Company Share (%), 2008 59
Figure 11: Clinical Chemistry, US, Company Share (%), 2008 61
Figure 12: Genetic Testing, US, Company Share (%), 2008 63
Figure 13: Haematology, US, Company Share (%), 2008 65
Figure 14: Histology And Cytology, US, Company Share (%), 2008 66
Figure 15: Immuno Chemistry, US, Company Share (%), 2008 67
Figure 16: Infectious Immunology, US, Company Share (%), 2008 69
Figure 17: Microbiology Culture, US, Company Share (%), 2008 71
Figure 18: In Vitro Diagnostics, Japan, Overall Revenue ($m), Historic, 2000-2008 72
Figure 19: In Vitro Diagnostics, Japan, Overall Revenue ($m), Forecast, 2008-2015 74
Figure 20: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015 76
Figure 21: In Vitro Diagnostics, Japan, Company Share (%), 2008 82
Figure 22: Clinical Chemistry, Japan, Company Share (%), 2008 84
Figure 23: Genetic Testing, Japan, Company Share (%), 2008 86
Figure 24: Haematology, Japan, Company Share (%), 2008 88
Figure 25: Histology And Cytology, Japan, Company Share (%), 2008 90
Figure 26: Immuno Chemistry, Japan, Company Share (%), 2008 92
Figure 27: Infectious Immunology, Japan, Company Share (%), 2008 94
Figure 28: Microbiology Culture, Japan, Company Share (%), 2008 96
Figure 29: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2000-2008 98
Figure 30: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2008-2015 100
Figure 31: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015 102
Figure 32: In Vitro Diagnostics, Germany, Company Share (%), 2008 108
Figure 33: Clinical Chemistry, Germany, Company Share (%), 2008 110
Figure 34: Genetic Testing, Germany, Company Share (%), 2008 112
Figure 35: Haematology, Germany, Company Share (%), 2008 113
Figure 36: Histology And Cytology, Germany, Company Share (%), 2008 115
Figure 37: Immuno Chemistry, Germany, Company Share (%), 2008 117
Figure 38: Infectious Immunology, Germany, Company Share (%), 2008 119
Figure 39: Microbiology Culture, Germany, Company Share (%), 2008 121
Figure 40: In Vitro Diagnostics, Italy, Overall Revenue ($m), Historic, 2000-2008 123
Figure 41: In Vitro Diagnostics, Italy, Overall Revenue ($m), Forecast, 2008-2015 125
Figure 42: In V